Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Rutenko, A. Baiganzhin, S. Baidurin, N. Popova (Astana, Kazakhstan). Serum and EBC levels of cross-linked carboxy-terminal telopeptide of type I collagen in young patients with non-CF bronchiectases. Eur Respir J 2009; 34: Suppl. 53, 3638

Member's Comments

No comment yet.

Related content which might interest you: Serum type III procollagen peptide in idiopathic pulmonary fibrosis: peptide levels and anti-fibrosis therapy Source: Eur Respir J 2005; 26: Suppl. 49, 30s Year: 2005 Type XIX collagen quantified in serum targeting the anti-tumorigenic NC1 domain is elevated in early and late stage lung carcinoma patients and COPD Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020 Serum levels of a MMP-12 generated type IV collagen fragment is elevated in COPD and IPF patients Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 The dynamics of IV-type collagen contents in BALF of patients with COPD Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012 Type I and III collagen protein precursors in the airways of smokers and COPD-patients Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008 A neo-epitope of collagen type VII (C7) is elevated in serum of patients with COPD and SSC Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 Collagen degradation profile in serum of patients with COPD or IPF Source: Annual Congress 2012 - Monitoring of airway diseases: far from the airways Year: 2012 Elevated type I collagen degradation predicts persistent asthma in children Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma Year: 2020 Diagnostic value of type I collagen cross-linked N-telopeptide in bone metastasis of lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 78s Year: 2004 A novel serum biomarker of type XXVIII collagen turnover is elevated in lung cancer but not in COPD Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020 Cystic fibrosis disease severity correlates with plasma levels of desmosine and isodesmosine, biomarkers of elastin degradation Source: ERJ Open Res, 5 (2) 00250-2018; 10.1183/23120541.00250-2018 Year: 2019 Increased levels of osteopontin in sputum supernatant in patients with COPD Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012 Elevated TNF-α and interleukin-6 levels in breath condensate and serum of patients with non-CF bronchiectasis: comparison to COPD Source: Eur Respir J 2005; 26: Suppl. 49, 227s Year: 2005 C-reactive protein and the type IV collagen measurementin severe COPD: Value of roflumilast Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 Serum lipid levels in patients with bronchiectasis Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Serum and BALF levels of YKL-40 in patients with alveolar proteinosis Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 Parameters of sIgE and sIgG4-autoAbs to lung elastin, collagen type III and myosin in bronchial asthma in association with chronic infection. Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases Year: 2019 KL-6 serum levels in adult cystic fibrosis patients Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies Year: 2011 Polymorphism of collagen COL1A1 gene and plasma NO level in severe bronchial asthma Source: Eur Respir J 2005; 26: Suppl. 49, 342s Year: 2005 Increased concentration of matrix metalloproteinase-9 in serum of COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 54s Year: 2005